Catalyst Pharmaceuticals (CPRX) EBIT (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) recorded EBIT of $73.23 million in Q1 2026, up 15.6% from $63.37 million a year earlier and up 18.4% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) EBIT (2010 - 2026) Analysis & Trends
On a TTM basis, Catalyst Pharmaceuticals' EBIT came in at $267.64 million as of Mar 31, 2026, up 15.7% year-over-year; for FY2025, it was $257.78 million, up 32.1% from FY2024.
- Annual EBIT has a five-year compound annual growth rate of 44.2% (FY2020 to FY2025).
- Across earlier years, EBIT came in at $195.12 million in FY2024 (+124.8%), $86.81 million in FY2023 (-14.8%), $101.84 million in FY2022 (+94.4%) and $52.39 million in FY2021 (+26.8%).
- The Q1 2026 figure is the highest quarterly EBIT in data going back to Q3 2010.
- On a year-over-year basis, EBIT rose in six of the last seven quarters, with growth averaging 38.1%.
- Peak year-over-year performance for EBIT in the last five years was growth of 141.7% in Q4 2022, against a decline of 23.8% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $61.85 million (Q4 2025), $66.27 million (Q3 2025) and $66.3 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 73.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 73.23 Mn |
| Dec 31, 2025 | 61.85 Mn |
| Sep 30, 2025 | 66.27 Mn |
| Jun 30, 2025 | 66.30 Mn |
| Mar 31, 2025 | 63.37 Mn |
| Dec 31, 2024 | 62.84 Mn |
| Sep 30, 2024 | 50.91 Mn |
| Jun 30, 2024 | 54.25 Mn |
| Mar 31, 2024 | 27.13 Mn |
| Dec 31, 2023 | 41.69 Mn |
| Sep 30, 2023 | -37.19 Mn |
| Jun 30, 2023 | 46.70 Mn |
| Mar 31, 2023 | 35.61 Mn |
| Dec 31, 2022 | 30.80 Mn |
| Sep 30, 2022 | 25.10 Mn |
| Jun 30, 2022 | 28.57 Mn |
| Mar 31, 2022 | 17.37 Mn |
| Dec 31, 2021 | 12.74 Mn |
| Sep 30, 2021 | 14.00 Mn |
| Jun 30, 2021 | 15.84 Mn |
API Access
Catalyst Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();